{"id":"W3170157402","doi":"10.1016/j.ctarc.2021.100421","title":"A phase I/II study of pembrolizumab in combination with nab-paclitaxel in patients with unresectable stage III or stage IV non small-cell lung carcinoma (NSCLC)","year":2021,"lang":"en","type":"article","venue":"Cancer Treatment and Research Communications","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"Queen's University; Centre Hospitalier de l’Université de Montréal","funders":"Merck","keywords":"Stage (stratigraphy); Pembrolizumab; Medicine; Oncology; Internal medicine; Paclitaxel; Nab-paclitaxel; Carcinoma; Chemotherapy; Cancer; Immunotherapy; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001581823,0.001866023,0.003002507,0.0006614834,0.0005937908,0.00133783,0.001190481,0.001528197,0.003727174],"category_scores_gemma":[0.0009810176,0.001020174,0.002060484,0.0006332431,0.001387852,0.001307319,0.000418985,0.004514818,0.001290031],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001176002,"about_ca_system_score_gemma":0.002137962,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002142601,"about_ca_topic_score_gemma":0.004760497,"domain_scores_codex":[0.999514,0.0002140484,0.00002039773,0.0001011077,0.00003511358,0.0001153551],"domain_scores_gemma":[0.9992895,0.0001140364,0.00008840667,0.00006421364,0.00003939293,0.0004044155],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8173984,0.08364935,0.004232902,0.0006717675,0.001597721,0.0002163459,0.0003174534,0.001739346,0.03018279,0.0002213877,0.002804334,0.05696812],"study_design_scores_gemma":[0.7273359,0.2615524,0.006529506,0.00002353977,0.0005809456,0.0001119063,0.00005828955,0.000606308,0.001572864,0.0001016031,0.001501534,0.00002532182],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9911293,0.002290776,0.0005408822,0.0007239284,0.0002583184,0.002236543,0.0009170498,0.00007957144,0.001823759],"genre_scores_gemma":[0.9854929,0.003283421,0.001861536,0.001094316,0.0003101601,0.003115082,0.002003134,0.00004733309,0.002792269],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003727174,"threshold_uncertainty_score":0.01246864,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07057552295191545,"score_gpt":0.3883166627883285,"score_spread":0.3177411398364131,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}